Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Stability in organic solvents and identity of relevant degradation products
Administrative data
Link to relevant study record(s)
- Endpoint:
- stability in organic solvents and identity of relevant degradation products
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 02 August 1016 to 30 August 2016
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with generally accepted scientific standards and described in sufficient detail
- Qualifier:
- no guideline required
- Principles of method if other than guideline:
- An HPLC method using Charged Aerosol Detection (CAD) for the determination of test item concentration ranging from 10 to 200 mg/L in formulations containing arachis (peanut) oil was validated. In addition, formulations prepared at target concentrations of 10 and 200 mg/L test item were analysed to assess test substance homogeneity and resuspension homogeneity/stability following storage for 6 and 11 days at room temperature.
- GLP compliance:
- yes
- Test substance stable:
- yes
- Transformation products:
- no
- Conclusions:
- Test item formulations prepared at target concentrations of 10 and 200 mg/mL in arachis (peanut) oil met the protocol-specified acceptance criteria with relative standard deviation for the mean concentration ≤ 10 % at a concentration within the acceptable limits (85 % to 115 % of target). Assessment of test substance resuspension homogeneity and stability in formulations prepared at target concentrations of 10 and 200 mg/mL met protocol-specified acceptance criteria following storage for 6 and 11 days at room temperature (relative standard deviation for the mean concentration was ≤ 10 % and post-storage concentration was not less than 90 % of the pre-storage value).
- Executive summary:
METHODS
An HPLC method using Charged Aerosol Detection for the determination of test item concentrations from 10 to 200 mg/L in formulations containing arachis (peanut) oil was validated. Test substance stability was also assessed in calibration standards and processed QC samples stored at room temperature for at least 11 days. Finally, formulations prepared at target concentrations of 10 and 200 mg/L test item were assessed for homogeneity plus resuspension homogeneity/stability after room temperature storage for 6 and 11 days.
RESULTS
The test item assay procedure was validated with 3 validation sessions. Quantitation was performed using calibration standards ranging in test substance concentration from 40.0 to 100 µg/mL. The mean back-calculated standard concentrations had inter-session variability ranged from 4.9% to 8.2% relative standard deviation (RSD) and percent relative error (%RE) ranged from -1.2% to 1.8%, which met the protocol-specified acceptance criteria for calibration standards (RSD ≤ 10% and %RE within ± 10% except at the lowest level where RSD ≤ 15% and %RE within ± 15% were acceptable). Assay precision and accuracy were verified by the analysis of QC samples prepared at 10.0, 100, and 200 mg/mL. The mean calculated QC concentrations had inter‑session variability (precision) ranging from 11% to 14% RSD and %RE (accuracy) ranging from -2.6% to 0.047%. The results met the protocol-specified acceptance criteria for precision and accuracy (RSD ≤ 15% and %RE within ± 15%).
The test substance in calibration standards and processed QC samples stored at room temperature for 11 days met the protocol-specified acceptance criteria for stability (the post-storage concentration was not < 90% of the pre-storage value).
Test item formulations prepared at target concentrations of 10 and 200 mg/mL met the protocol-specified acceptance criteria with relative standard deviation for the mean concentration ≤ 10 % at a concentration within the acceptable limits (85 % to 115 % of target). Assessment of test substance resuspension homogeneity and stability in formulations prepared at target concentrations of 10 and 200 mg/mL met protocol-specified acceptance criteria following storage for 6 and 11 days at room temperature (relative standard deviation for the mean concentration was ≤ 10 % and post-storage concentration was not less than 90 % of the pre-storage value).
Reference
RESULTS
- Under the described chromatographic conditions, the retention time of the test substance was approximately 10.8 minutes.
- Figures 1 to 4 (attached) are typical chromatograms of a calibration standard, a processed QC sample, a processed formulation sample, and a processed vehicle blank sample, respectively.
- The total analysis time required for each run was 17.0 minutes.
SPECIFICITY/SELECTIVITY
- As shown in Figure 4 (attached) (and in contrast to the chromatograms shown in Figure 1, Figure 2, and Figure 3, attached), assay specificity/selectivity was confirmed when HPLC/CAD analysis of processed vehicle samples revealed no significant peaks (with S/N > 10) at or near the retention time for the test substance (approximately 10.8 minutes).
ASSAY VALIDATION – CALIBRATION REPRODUCIBILITY
- During each of 3 validation sessions, triplicate calibration standards at 5 concentrations were prepared and analysed. Single injections were made of each calibration standard. The resulting test item peak area versus theoretical test item concentration data were fit to the quadratic function using least-squares regression analysis.
- The results of the regression analyses were used to back-calculate the corresponding concentrations from the peak area data. As per the protocol, the reproducibility of the calibration curve data was considered valid when 1) the inter-session variability, expressed as RSD, of the back-calculated concentrations at each calibration level was ≤ 10% RSD, except at the lowest calibration level where ≤ 15% was acceptable; and 2) the mean back-calculated concentrations at each calibration level were within ± 10% of the theoretical values (%RE within ± 10%), except at the lowest calibration level where %RE within ± 15% was acceptable.
- The back-calculated concentrations and the associated intra- and inter-session statistics for the test item assay calibration standards are summarized in Table 1 (attached). The inter-session variability (RSD) of the back-calculated concentrations ranged from 4.9% to 8.2% RSD. The inter-session mean concentrations had %RE values ranging from -1.2% to 1.8%. Based on the stated criteria, the reproducibility of the calibration data was acceptable.
ASSAY VALIDATION – PRECISION AND ACCURACY
- During each of 3 validation sessions, triplicate QC samples at 3 concentrations were prepared and analysed. Single injections were made of each processed QC sample. The results of the regression analyses were used to calculate the corresponding concentrations from the QC peak area data. The variability (RSD) of the calculated QC concentration data was used as a measure of assay precision, and the difference between the theoretical and calculated mean QC concentrations (%RE) was used as a measure of assay accuracy. According to the protocol, the precision of the method was considered acceptable when the inter-session RSD of the calculated concentrations at each QC level was ≤ 15%, and the accuracy of the method was considered acceptable when the inter-session calculated mean concentration at each QC level had a %RE value within ± 15%.
- The calculated concentrations and the associated intra- and inter-session statistics for the test item assay QC samples are summarized in Table 2. The inter-session variability (RSD) of the calculated concentrations of each QC sample (precision) ranged from 11% to 14% RSD. The inter-session mean concentrations of the QC samples had %RE values (accuracy) ranging from -2.6% to 0.047%. Based on the stated criteria, the precision and accuracy of the test item assay were acceptable.
ASSAY RUGGEDNESS
- Assay ruggedness, as required by the SOP, was successfully demonstrated for this method because at least 2 of the 3 validation sessions were performed by different analysts.
ASSAY ACCEPTABILITY
- In addition to the experimental samples, each analytical session consisted of (but was not limited to) calibration standards at 5 concentrations and triplicate QC samples prepared at each of at least 2 concentrations. In this study, the formulations were prepared at test item target concentrations of 10 and 200 mg/mL, and the QC samples were prepared at nominal concentrations of 10.0, 100, and 200 mg/mL. According to SOP, for an analytical session to be considered valid, at least two-thirds of the calculated QC concentrations with at least 1 sample at each concentration had to be 85% to 115% of the nominal QC concentration. All reported results were from analytical sessions that met the acceptance criteria.
TEST SUBSTANCE STABILITY IN CALIBRATION STANDARDS
- Calibration standards prepared at 40.0 and 100 µg/mL and analysed were stored at room temperature for 11 days before re-analysis to assess test substance stability.
- The mean post‑storage concentrations ranged from 99.2% to 111% of the pre-storage values (Table 3), which met the (previously stated) protocol-specified requirement for stability (the mean post-storage concentration was not < 90% of the pre-storage value).
TEST SUBSTANCE STABILITY IN PROCESSED SAMPLES
- QC samples prepared at nominal test substance concentrations of 10.0 and 200 mg/mL were processed and analysed.
- The processed samples were stored at room temperature for 11 days before re-analysis to assess test substance stability.
- The mean post-storage concentrations were 91.5% and 100% of the pre-storage values (Table 3, attached), which met the (previously stated) protocol‑specified requirement for stability (the mean post-storage concentration was not < 90% of the pre-storage value).
TEST SUBSTANCE HOMOGENEITY AND RESUSPENSION HOMOGENEITY ASSESSMENT OF FORMULATIONS
- Duplicate samples from the top, middle, and bottom strata of the formulations prepared on 18 Aug 2016 at target test substance concentrations of 10 and 200 mg/mL were analysed to assess test substance homogeneity. The formulations that remained after sampling were divided into aliquots as would be used for daily dispensation. - Representative aliquots were stored at room temperature for 6 and 11 days, at which time the test substance was resuspended by stirring. Duplicate samples were collected from the top and bottom strata of the aliquots and analysed to assess resuspension homogeneity.
- The results of the homogeneity and resuspension homogeneity analyses are presented in Table 4, Table 5, and Table 6 (attached), with the overall statistics summarised in Text Table 3, Text Table 4, and Text Table 5 (below).
TEST SUBSTANCE STABILITY IN FORMULATIONS
- Formulations prepared at target test item concentrations of 10 and 200 mg/mL were analysed on the day of preparation.
- Portions of the formulations were stored at room temperature before being analysed to assess test substance stability.
- The stability results are presented in Table 7 and Table 8 (attached), with the mean concentration and percent of time-zero values summarized in Text Table 6 (below).
- The post-storage test substance concentrations ranged from 91.6% to 110% of the pre-storage values, which met the (previously stated) protocol-specified requirement for stability, (the mean post-storage concentration was not < 90% of the pre-storage value).
TEXT TABLE 3: HOMOGENEITY ASSESSMENT OF THE 18 AUG 2016 FORMULATIONS
|
Low group (10 mg/L) |
High group (200 mg/L) |
Mean concentration (mg/mL) |
11.5 |
214 |
SD |
0.76 |
21 |
RSD (%) |
6.6 |
9.9 |
Mean concentration % of target |
115 |
107 |
TEXT TABLE 4: SIX-DAY ROOM TEMPERATURE STORAGE RESUSPENSION HOMOGENEITY ASSESSMENT OF THE 18 AUG 2016 FORMULATIONS
|
Low group (10 mg/L) |
High group (200 mg/L) |
Mean concentration (mg/mL) |
10.2 |
232 |
SD |
1.0 |
12 |
RSD (%) |
9.8 |
5.0 |
Mean concentration % of target |
102 |
116 |
TEXT TABLE 5: ELEVEN-DAY ROOM TEMPERATURE STORAGE RESUSPENSION HOMOGENEITY ASSESSMENT OF THE 18 AUG 2016 FORMULATIONS
|
Low group (10 mg/L) |
High group (200 mg/L) |
Mean concentration (mg/mL) |
9.14 |
129 |
SD |
0.92 |
8.2 |
RSD (%) |
10 |
6.3 |
Mean concentration % of target |
91.4 |
64.7 |
TEXT TABLE 6: TEST SUBSTANCE STABILITY IN FORMULATIONS
|
Storage duration |
Mean concentration in mg/mL (% of time zero) for Low group (10 mg/mL) |
Mean concentration in mg/mL (% of time zero) for high group (200 mg/mL) |
Room temperature |
6 days |
10.5 (91.6) |
199 (92.9) |
Room temperature |
11 days |
12.2 (106) |
237 (110) |
Description of key information
Formulations prepared at target concentrations of 10 and 200 mg/mL met the protocol-specified acceptance criteria with relative standard deviation for the mean concentration ≤ 10 % at a concentration within the acceptable limits (85 % to 115 % of target). Assessment of test substance resuspension homogeneity and stability in formulations prepared at target concentrations of 10 and 200 mg/mL met protocol-specified acceptance criteria following storage for 6 and 11 days at room temperature (relative standard deviation for the mean concentration was ≤ 10 % and post-storage concentration was not less than 90 % of the pre-storage value).
Additional information
METHODS
An HPLC method using Charged Aerosol Detection for the determination of test item concentrations from 10 to 200 mg/L in formulations containing arachis (peanut) oil was validated. Test substance stability was also assessed in calibration standards and processed QC samples stored at room temperature for at least 11 days. Finally, formulations prepared at target concentrations of 10 and 200 mg/L test item were assessed for homogeneity plus resuspension homogeneity/stability after room temperature storage for 6 and 11 days.
RESULTS
The test item assay procedure was validated with 3 validation sessions. Quantitation was performed using calibration standards ranging in test substance concentration from 40.0 to 100 µg/mL. The mean back-calculated standard concentrations had inter-session variability ranged from 4.9% to 8.2% relative standard deviation (RSD) and percent relative error (%RE) ranged from -1.2% to 1.8%, which met the protocol-specified acceptance criteria for calibration standards (RSD ≤ 10% and %RE within ± 10% except at the lowest level where RSD ≤ 15% and %RE within ± 15% were acceptable). Assay precision and accuracy were verified by the analysis of QC samples prepared at 10.0, 100, and 200 mg/mL. The mean calculated QC concentrations had inter‑session variability (precision) ranging from 11% to 14% RSD and %RE (accuracy) ranging from -2.6% to 0.047%. The results met the protocol-specified acceptance criteria for precision and accuracy (RSD ≤ 15% and %RE within ± 15%).
The test substance in calibration standards and processed QC samples stored at room temperature for 11 days met the protocol-specified acceptance criteria for stability (the post-storage concentration was not < 90% of the pre-storage value).
Formulations prepared at target concentrations of 10 and 200 mg/mL met the protocol-specified acceptance criteria with relative standard deviation for the mean concentration ≤ 10 % at a concentration within the acceptable limits (85 % to 115 % of target). Assessment of test substance resuspension homogeneity and stability in formulations prepared at target concentrations of 10 and 200 mg/mL met protocol-specified acceptance criteria following storage for 6 and 11 days at room temperature (relative standard deviation for the mean concentration was ≤ 10 % and post-storage concentration was not less than 90 % of the pre-storage value).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.